1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    Red line going down on an ASX market chart which symbolises a falling share price.
    Share Market News

    ASX 200 midday update: Aristocrat's earnings beat, Webjet flops, retailers smashed

    | James Mickleboro

    The ASX 200 is deep in the red on Thursday...

    Read more »

    Person pointing at an increasing blue graph which represents a rising share price.
    Healthcare Shares

    Here's why the Imugene share price just got a boost

    | Aaron Teboneras

    Imugene's latest announcement is rallying up investors.

    Read more »

    Red arrow going down, symbolising a falling share price.
    Share Fallers

    Why Imugene, Integrated Research, Monash IVF, and Step One shares are sinking

    | James Mickleboro

    These ASX shares are falling on Monday...

    Read more »

    A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
    Share Market News

    ASX 200 midday update: Brambles rockets, Goodman upgrades guidance

    | James Mickleboro

    The ASX 200 is having a decent start to the week...

    Read more »

    Person with thumbs down and a red sad face poster covering the face.
    Share Fallers

    Why A2 Milk, Imugene, Liontown, and Magellan shares are tumbling lower

    | James Mickleboro

    These ASX shares are falling hard on Monday...

    Read more »

    A girl wearing yellow headphones pulls a grimace, that was not a good result.
    Share Fallers

    These were the worst performers on the ASX 200 last week

    | James Mickleboro

    These ASX 200 shares were sold off last week...

    Read more »

    A man analyses stockmarket graph on his computer.
    Share Market News

    ASX 200 midday update: NAB disappoints, Qantas announces acquisition

    | James Mickleboro

    The ASX 200 is having a better day on Thursday...

    Read more »

    A man working in the stock exchange.
    Share Market News

    ASX 200 midday update: ANZ higher on results, Flight Centre and JB Hi-Fi sink following updates

    | James Mickleboro

    Here's what is happening on the ASX 200 today...

    Read more »

    Two researchers discussing results of a study with each other.
    Healthcare Shares

    Imugene share price seesaws on 'clarification announcement'

    | Aaron Teboneras

    What did Imugene update the ASX with?

    Read more »

    A female scientist sits at her desk looking stressed out while working in an AnteoTech lab.
    Healthcare Shares

    Here's why the Imugene share price is plunging 15% today

    | Aaron Teboneras

    The company's latest announcement has sent investors fleeing for the hills...

    Read more »

    A happy man and woman sit having a coffee in a cafe while she holds up her phone to show him the ASX shares that did best today.
    Share Market News

    ASX 200 midday update: AMP asset sale talks, Syrah rockets

    | James Mickleboro

    The ASX 200 is having a good day...

    Read more »

    a woman rugged up in a woolen hat and gloves with a thermometer in her mouth props her hand under her chin as she looks dejectedly at the camera,, as though she is miserable from feeling sick.
    Healthcare Shares

    ASX 200 healthcare shares were chronically ill last quarter. Take a look

    | Zach Bristow

    They aren't exactly on the mend either.

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note